Clinical Trial: PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea
Study Status: Completed
Recruit Status: RECRUITING
Condition: Seborrheic Dermatitis
Study Type: INTERVENTIONAL
Official Title: PDE4 Inhibition in the Treatment of Seborrheic Dermatitis and Papulopustular Rosacea With PF-07038124
Brief Summary:
This study is a double-blind, vehicle-controlled clinical trial.The study will take place at Icahn School of Medicine at Mount Sinai.The study will include 33-39 adult subjects with moderate-to-severe-Seborrheic dermatitis (SD) as well as 33-39 adult subjects with moderate-to-severe papulopustular rosacea (PPR).Subjects will be randomized 2:1 to receive study drug or placebo.Enrolled subjects will apply topical PF-07038124 0.02% ointment once daily for 8 weeks.They will return for visits at weeks 4, 8, and 12…
Read more